纳米技术
胶体金
纳米颗粒
商业化
生物相容性材料
材料科学
医学
业务
生物医学工程
营销
作者
Yogita Kumari,Gurmandeep Kaur,Rajesh Kumar,Sachin Kumar Singh,Monica Gulati,Rubiya Khursheed,Clarisse Ayinkamiye,Gowthamarajan Kuppusamy,Veera Venkata Satyanarayana Reddy Karri,Ravichandran Mahalingam,Dipanjoy Ghosh,Ankit Awasthi,Rajan Kumar,Ankit Yadav,Bhupinder Kapoor,Pankaj Kumar Singh,Kamal Dua,Omji Porwal
标识
DOI:10.1016/j.cis.2019.102037
摘要
In recent years, gold nanoparticles have emerged as unique non-invasive drug carriers for targeting drugs to their site of action. Their site specificity has helped in increasing drugs' efficacy at lower dose as well as reduction in their side effects. Moreover, their excellent optical properties and small size offer their utilization as diagnostic tools to diagnose tumors as well as other diseases. This review focuses on various approaches that have been used in last several years for preparation of gold nanoparticles, their characterization techniques and theranostic applications. Their toxicity related aspects are also highlighted. Gold nanoparticles are useful as theranostic agents, owing to their small size, biocompatible nature, size dependent physical, chemical and optical properties etc. However, the challenges associated with these nanoparticles such as scale up, cost, low drug payload, toxicity and stability have been the major impediments in their commercialization. The review looks into all these critical issues and identifies the possibilities to overcome these challenges for successful positioning of metallic nanoparticles in market.
科研通智能强力驱动
Strongly Powered by AbleSci AI